The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8999957, Table 2, Compound 55 ID: ALA3654530
Chembl Id: CHEMBL3654530
PubChem CID: 89509116
Max Phase: Preclinical
Molecular Formula: C25H25FN6O
Molecular Weight: 444.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CCCN(Cc5ncccc5F)C4)cc23)ccn1
Standard InChI: InChI=1S/C25H25FN6O/c1-16-12-17(8-10-27-16)24-20-13-18(6-7-22(20)30-31-24)25(33)29-19-4-3-11-32(14-19)15-23-21(26)5-2-9-28-23/h2,5-10,12-13,19H,3-4,11,14-15H2,1H3,(H,29,33)(H,30,31)/t19-/m1/s1
Standard InChI Key: APADOXMKQCWQGW-LJQANCHMSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.51Molecular Weight (Monoisotopic): 444.2074AlogP: 3.86#Rotatable Bonds: 5Polar Surface Area: 86.80Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.21CX Basic pKa: 6.24CX LogP: 2.53CX LogD: 2.50Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.76
References 1. (2015) Heterocyclic compounds as ERK inhibitors,